SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	12 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Feb. 03, 2023	Jan. 04, 2021	Dec. 21, 2020
Product Information [Line Items]
FDIC limits per institutions	$ 250,000
Cash Balances	3,731,290
Revenues	6,491,008	$ 5,597,487
Cost of revenues	753,534	547,881
Bad debt expense	27,500	$ 0
Inventory Reserve	37,455
Incremental salary		35,684,900
Research and Development Expense	$ 791,326	$ 1,120,067
Common stock, shares authorized	2,500,000,000	2,500,000,000		2,500,000,000	1,500,000,000
Common stock, shares issued	1,479,126,390	1,132,361,005
Common stock, shares outstanding	1,479,126,390	1,132,361,005
Operating and finance lease obligation	$ 15,000
Subsequent Event [Member]
Product Information [Line Items]
Common stock, shares authorized			2,500,000,000
Common stock, shares issued			1,463,957,717
Common stock, shares outstanding			1,463,957,717
Common Shares Issuable Upon Exercise Of Warrants [Member]
Product Information [Line Items]
Antidilutive securities excluded from computation of earnings per share	388,048,326	9,500,000
Minimum [Member]
Product Information [Line Items]
Property, plant and equipment, estimated useful lives	3 years
Maximum [Member]
Product Information [Line Items]
Property, plant and equipment, estimated useful lives	15 years
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Large Distributor And Distributors Customers [Member]
Product Information [Line Items]
Revenues	$ 2,124,000	$ 2,140,000
Concentration credit risk percentage	32.70%	37.60%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customers Of Another Distributor [Member]
Product Information [Line Items]
Revenues	$ 1,413,700	$ 709,000
Concentration credit risk percentage	21.80%	12.50%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Management Services Organization [Member]
Product Information [Line Items]
Revenues	$ 702,100	$ 881,600
Concentration credit risk percentage	10.80%	15.70%
Tissue Raw Material [Member] | Customer Concentration Risk [Member] | First Supplier [Member]
Product Information [Line Items]
Concentration credit risk percentage	53.00%	53.00%
Cost of revenues	$ 145,000	$ 148,600
Tissue Raw Material [Member] | Customer Concentration Risk [Member] | Second Supplier [Member]
Product Information [Line Items]
Concentration credit risk percentage	47.00%	47.00%
Cost of revenues	$ 130,000	$ 131,600